The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical outcomes with perioperative nivolumab (NIVO) by nodal status among patients (pts) with stage III resectable NSCLC: Results from the phase 3 CheckMate 77T study.
 
Mariano Provencio
Honoraria - AstraZeneca; BMS; Janssen; Lilly; MSD; Pfizer; Roche; Roche; Takeda
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Janssen Oncology; Lilly; Merck; MSD; Pfizer; Roche; Roche; Takeda
Speakers' Bureau - AstraZeneca; BMS; MSD; Pfizer; Roche; Takeda
Research Funding - AstraZeneca; Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); MSD; Pfizer; Pierre Fabre (Inst); Roche (Inst); Takeda
Travel, Accommodations, Expenses - AstraZeneca; BMS; Boehringer Ingelheim; Bristol Myers Squibb Company; Lilly; MSD; Pierre Fabre; Roche; ROCHE; Takeda
Other Relationship - Pfizer
 
Mark M. Awad
Consulting or Advisory Role - Affini-T Therapeutics; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; EMD Serono; Foundation Medicine; Gritstone Bio; Instil Bio; Janssen; Merck; Mirati Therapeutics; Novartis; Pfizer; Regeneron
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst)
Travel, Accommodations, Expenses - Bristol Myers Squibb Foundation
 
Jonathan Spicer
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb/Medarex; Chemocentryx; Merck; Novartis; Pfizer
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb/Medarex; Merck; Protalix Biotherapeutics; Regeneron; Xenetic Biosciences
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb/Medarex (Inst); CLS-Therapeutics (Inst); CLS-Therapeutics (Inst); Merck (Inst); Protalix Biotherapeutics (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb/Medarex; Merck
 
Annelies Janssens
Travel, Accommodations, Expenses - Roche (Inst)
 
Fedor Vladimirovich Moiseenko
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Lilly; Roche
Speakers' Bureau - AstraZeneca; BIOCAD; Novartis; Pfizer; Roche; Svixx
Expert Testimony - Novartis; Pfizer
Travel, Accommodations, Expenses - AstraZeneca; BIOCAD; Novartis; Pfizer; R-Pharm; Roche
 
Yang Gao
No Relationships to Disclose
 
Yasutaka Watanabe
No Relationships to Disclose
 
Aurelia Alexandru
Consulting or Advisory Role - Boehringer Ingelheim; Roche
Expert Testimony - Bristol-Myers Squibb; Novartis; Sandoz
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Pfizer; Roche; Sanofi
 
Florian Guisier
Honoraria - Amgen; AstraZeneca; BMS GmbH & Co. KG; Janssen; MSD; Pfizer; Roche; Sanofi; Takeda; Viatris
Consulting or Advisory Role - Amgen; AstraZeneca; BMS GmbH & Co. KG; MSD; Roche; Sanofi
Research Funding - Pfizer (Inst); Roche (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; MSD; Takeda
 
Nikolaj Frost
Honoraria - Abbvie; Amgen; AstraZeneca; BeiGene; Berlin-Chemie; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; Janssen Oncology; Lilly; Merck Serono; MSD Oncology; Novartis; Pfizer; Roche Pharma AG; Sanofi/Aventis; Takeda
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen Oncology; Lilly; Merck Serono; MSD Oncology; Novartis; Pfizer; Roche Pharma AG; Sanofi/Aventis; Takeda
Research Funding - Roche Pharma AG
Travel, Accommodations, Expenses - Abbvie; AstraZeneca; Bristol-Myers Squibb; Lilly; Roche Pharma AG; Takeda
(OPTIONAL) Uncompensated Relationships - Deutsche Forschungsgemeinschaft; Deutsche Krebsgesellschaft, Arbeitsgemeinschaft Internistische Onkologie; German Society for Pneumology and Respiratory Medicine
 
Fabio A. Franke
No Relationships to Disclose
 
T.Jeroen Jeroen Nicolaas Hiltermann
Consulting or Advisory Role - BMS (Inst)
Research Funding - AZD (Inst); BMS (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Roche (Inst)
 
Jie He
No Relationships to Disclose
 
Fumihiro Tanaka
Consulting or Advisory Role - AstraZeneca; Chugai Pharma; Ono Pharmaceutical
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Covidien; Illy Lilly Japan; Intuitive Japan; JJ Innovative Medicine; Kyowa Kirin; MSD; Olympus; Ono Pharmaceutical; Pfizer; Stryker; Taiho pharmaceutical; Takeda
Research Funding - Boehringer Ingelheim; Chugai Pharma; Illy Lilly Japan; Ono Pharmaceutical; Taiho Pharmaceutical
 
Shun Lu
Leadership - Innovent BIOLOGICS, INC
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; GenomiCare; Hutchison MediPharma; InventisBio Co. Ltd; Menarini; Pfizer; Roche; Simcere; Yuhan; Zai Lab
Speakers' Bureau - AstraZeneca; Hansoh Pharma; Hengrui Therapeutics; Roche
Research Funding - AstraZeneca (Inst); BeiGene (Inst); BMS (Inst); Hansoh (Inst); Hengrui Therapeutics (Inst); Hutchison MediPharma (Inst); Lilly Suzhou Pharmaceutical Co. (Inst); Roche (Inst)
 
Cinthya Coronado Erdmann
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb; Incyte
 
Padma Sathyanarayana
No Relationships to Disclose
 
Phuong Tran
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Vipul Devas
Employment - Bristol-Myers Squibb Hong Kong
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Tina Cascone
Honoraria - Brystol-Myers Squibb; IDEOlogy Health; Mark Foundation for Cancer Research; Medscape; Onclive; Peerview; Roche; Society for Immunotherapy of Cancer
Consulting or Advisory Role - Arrowhead Pharmaceuticals; Bristol Myers Squibb; EMD Serono; Genentech; MedImmune; Merck; Regeneron
Research Funding - AstraZeneca (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); MedImmune (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Dava Oncology; IASLC; IDEOlogy Health; Parker Institute for Cancer Immunotherapy; Society for Immunotherapy of Cancer